See all news

STAAR Surgical Company Announces Conference Call to Discuss Second Quarter Results

  • 2001-10-19
  • Press release
MONROVIA, Calif., Oct 19, 2001 /PRNewswire via COMTEX/ -- STAAR Surgical Company (Nasdaq: STAA) today announced that it will have an investor conference call following the release of its third quarter financial results. The conference call will be placed on Wednesday, October 24, 2001 at 1:30 p.m. Pacific time, 4:30 Eastern time.

On the day of the conference call participants should dial (800) 567-7916 ten minutes before the scheduled start of the conference call and ask for conference ID#2067592. A tape replay of the call will be available two hours after the conclusion of the conference through Tuesday, October 30, 2001 by dialing (800) 642-1687 and giving the conference ID#2067592.

It is STAAR Surgical's policy to comply fully with Regulation FD. Therefore, STAAR intends to utilize this web cast conference call to discuss financially oriented goals and objectives and to disclose material Company and industry-based topics in an open manner. The Company does not plan to report or comment on its progress during the quarter. Any statement made by others with respect to progress mid-quarter cannot be attributed to the Company. During a quarter, the Company's commentary will be limited to discussions of public information, such as historic financial performance, and matters that are deemed to be immaterial. STAAR will make no comments with respect to market rumors or speculation.

Founded in 1982, STAAR Surgical Company develops, manufactures and globally distributes medical devices for use in refractive, cataract and glaucoma surgery. The Company's five product lines include silicone and Collamer(TM) foldable intraocular lenses and the Sonic WAVE(TM) phacoemulsification system, all of which are used during cataract surgery, the ICL(TM) (implantable contact lens) that is a refractive lens for the treatment of near- and far-sightedness and the AquaFlow(TM) collagen glaucoma drainage device. Regulatory approvals vary from market to market with all products available in Europe and all except the ICL(TM) in the United States.

Certain statements in this press release constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on expectations as of the date of a particular release. Actual results may differ materially from those projected because of a number of risks and uncertainties, including those detailed from time to time in STAAR Surgical Company's reports filed with the Securities and Exchange Commission.

For additional information, about STAAR Surgical Company, visit the Company's web site at or . You may wish to contact David Bailey, President, STAAR Surgical, or John Santos, Chief Financial Officer, STAAR Surgical, at (626) 303-7902. To contact Bill Roberts, President, CTC, Inc., or Wayne Buckhout, CTC Inc., please call (937) 434-2700.

                       MAKE YOUR OPINION COUNT - Click Here
SOURCE STAAR Surgical Company

CONTACT:          David Bailey, President, or John Santos, Chief Financial
                  Officer of STAAR Surgical, +1-626-303-7902; or Bill Roberts, President, or
                  Wayne Buckhout of CTC Inc., +1-937-434-2700

Copyright (C) 2001 PR Newswire.  All rights reserved.